Vagus Nerve Stimulation Market Report 2026

Vagus Nerve Stimulation Market Overview

• Vagus Nerve Stimulation market size has reached to $1.02 billion in 2025 • Expected to grow to $2.02 billion in 2030 at a compound annual growth rate (CAGR) of 14.5% • Growth Driver: Increasing Prevalence Of Neurological Conditions Spurs Expansion In Vagus Nerve Stimulation Market • Market Trend: Innovative Advancements In Vagus Nerve Stimulation Therapy • North America was the largest region in 2025.

What Is Covered Under Vagus Nerve Stimulation Market?

Vagus nerve stimulation (VNS) is a medical treatment that involves delivering electrical impulses to the vagus nerve, a major nerve that runs from the brainstem down to the abdomen, influencing various body functions such as heart rate, digestion, and mood regulation. The treatment is primarily used to manage epilepsy, treatment-resistant depression, and other neurological conditions. The main vagus nerve stimulation products include implantable vagus nerve stimulation devices and external vagus nerve stimulation devices. An implantable vagus nerve stimulation (VNS) device is a surgically implanted medical device that delivers electrical impulses to the vagus nerve, typically located in the neck, to help treat conditions such as epilepsy and depression. It is made using various types of biomaterials, such as metallic, ceramic, and polymeric, and is applied for epilepsy, depression, and migraine. It is used by several end-use industries, including hospitals, neurology clinics, ambulatory surgical centers, and research centers.

What Is The Vagus Nerve Stimulation Market Growth Forecast?

The vagus nerve stimulation market size is expected to see rapid growth in the next few years. It will grow to $2.02 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to increasing demand for personalized neuromodulation therapies, rising adoption of wearable medical devices, expansion of neurological disorder treatment options, growing focus on non-pharmacological interventions, ongoing innovation in stimulation technologies. Major trends in the forecast period include increasing adoption of non-invasive vns devices, rising use of vns in depression management, growing integration of wearable neuromodulation technologies, expansion of home-based neuromodulation therapies, enhanced focus on patient-specific stimulation protocols.

What Is The Driver Of The Vagus Nerve Stimulation Market?

The increasing prevalence of neurological disorders is expected to propel the growth of the vagus nerve stimulation market going forward. A neurological disorder is a condition that affects the brain, spinal cord, or nerves, leading to problems with movement, sensation, cognition, or overall function. The causes of neurological disorders are diverse and can involve a combination of genetic, environmental, and lifestyle factors. Additionally, physical injuries, such as head injuries and spinal cord injuries, can lead to neurological problems. Vagus nerve stimulation is used to manage neurological disorders because it modulates brain activity and neurotransmitter levels, helping to reduce symptoms in conditions such as epilepsy, depression, and certain types of migraines. For instance, in September 2024, according to the Australian Institute of Health and Welfare, an Australian-based government agency, it is estimated that 411,100 Australians were living with dementia in 2023 and is projected to more than double by the year 2058. Therefore, the increasing prevalence of neurological disorders drives the vagus nerve stimulation industry.

Key Players In The Global Vagus Nerve Stimulation Market

Major companies operating in the vagus nerve stimulation market are Medtronic PLC, Boston Scientific Corporation, LivaNova LLC, electroCore Inc., Soterix Medical Inc., Cleveland Medical Devices Inc., MicroTransponder Inc., Parasym Ltd., Neuvana LLC, NeuroSigma Inc., Evren Technologies Inc., Aucta Technologies Inc., SetPoint Medical Corporation, NEMOS GmbH, tVNS Technologies GmbH, Innervate Inc., Neuroelectrics Barcelona S.L., Brainstem Biometrics Inc., BioControl Medical Ltd., Cala Health Inc.

Global Vagus Nerve Stimulation Market Trends and Insights

Major companies operating in the vagus nerve stimulation market are focused on developing technologically advanced products, such as implantable pulse generators (IPG), to offer long-term, adjustable, and targeted therapy for chronic conditions. An implantable pulse generator (IPG) is a medical device surgically placed under the skin that delivers electrical pulses to specific body areas to treat conditions like chronic pain or neurological disorders. For instance, in February 2023, LivaNova Plc, a UK-based medical device company, launched the SenTiva DUO. The SenTiva DUO is a distinctive implantable pulse generator (IPG) crafted for vagus nerve stimulation (VNS) therapy, tailored specifically for treating drug-resistant epilepsy. This innovative device allows patients with legacy dual-pin systems to upgrade without requiring lead revisions, offering advanced VNS therapy with customizable, automatic delivery. SenTiva DUO enhances seizure control and supports optimal treatment adherence, making it a significant advancement for those seeking effective management of their condition.

What Are Latest Mergers And Acquisitions In The Vagus Nerve Stimulation Market?

In June 2023, SCREEN Holdings Co. Ltd., a Japan-based semiconductor company, acquired shares in Adriakaim Inc. for an undisclosed amount. Following the acquisition, SCREEN plans to collaborate with Adriakaim to expedite the commercialization of its vagus nerve stimulation device. Additionally, SCREEN will persist in addressing various needs within the medical field, thereby contributing to solving a range of societal issues. Adriakaim Inc. is a Japan-based manufacturer of vagus nerve stimulation devices.

What Defines the Vagus Nerve Stimulation Market?

The vagus nerve stimulation market consists of sales of non-invasive VNS devices, stimulation generators, lead wires and electrodes, rechargeable VNS devices and wearable VNS patches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Vagus Nerve Stimulation Market Report 2026?

The vagus nerve stimulation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the vagus nerve stimulation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.